aTyr Pharma, Inc. (ATYR)
NASDAQ·Healthcare·Biotechnology
$0.52
+6.69%
Mkt Cap $47.06M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (4 analysts)
$5.13
Range $1.00 – $17.00
Implied Upside
+877.3%
Consensus $5.13 vs current $0.52
NASDAQ·Healthcare·Biotechnology
$0.52
+6.69%
Mkt Cap $47.06M
Buy
1
Hold
0
Sell
0
Price Target (4 analysts)
$5.13
Range $1.00 – $17.00
+877.3%
Consensus $5.13 vs current $0.52